Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
66.5M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
8.57M
-
Shares change
-
+426K
-
Total reported value, excl. options
-
$49.5M
-
Value change
-
+$2.1M
-
Put/Call ratio
-
0.72
-
Number of buys
-
41
-
Number of sells
-
-35
-
Price
-
$5.78
Significant Holders of INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO) as of Q3 2024
116 filings reported holding INO - INOVIO PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2024.
INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.57M shares
of 66.5M outstanding shares and own 12.88% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.89M shares), Deep Track Capital, LP (1.8M shares), VANGUARD GROUP INC (1.8M shares), GEODE CAPITAL MANAGEMENT, LLC (622K shares), STATE STREET CORP (491K shares), RENAISSANCE TECHNOLOGIES LLC (331K shares), NORTHERN TRUST CORP (206K shares), DIMENSIONAL FUND ADVISORS LP (131K shares), GMT CAPITAL CORP (126K shares), and MORGAN STANLEY (95.1K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.